Market Tracker

09/22 6:05pm ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

4.24
Data as of Sep 22
 +0.09 / +2.17%
Today’s Change
3.81
Today|||52-Week Range
7.90
-30.15%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close4.15
Today’s open4.36
Day’s range4.04 - 4.38
Volume171,439
Average volume (3 months)74,245
Market cap$146.9M
Dividend yield--
Data as of 3:59pm ET, 09/22/2014

Growth & Valuation

Earnings growth (last year)+39.13%
Earnings growth (this year)-14.29%
Earnings growth (next 5 years)--
Revenue growth (last year)+9.32%
P/E ratioNM
Price/Sales61.71
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MDWDMediwound Ltd-0.01-0.14%
AFMDAffimed Therapeutics...+0.18+2.91%
MEIPMEI Pharma Inc+0.18+2.67%
DSCODiscovery Laboratori...-0.03-1.71%
Data as of 3:59pm ET, 09/22/2014

Financials

Next reporting dateNovember 14, 2014
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$3.4M
Annual profit (last year)-$4.9M
Net profit margin-146.13%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
André Monette
Corporate headquarters
Saint-Laurent, Quebec

Forecasts